C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/44 (2006.01) A61K 31/55 (2006.01) A61K 31/7088 (2006.01) A61K 38/00 (2006.01) A61K 39/395 (2006.01) A61P 37/06 (2006.01)
Patent
CA 2686722
We have discovered that administering anti-ceramide antibody treats and prevents an array of diseases mediated by cytolytic T lymphocyte (CTLs)-induced killing and by damage to endothelial microvasculture, including radiation-induced GI syndrome, Graft vs. Host diseases, inflammatory diseases and autoimmune diseases. We have also discovered new anti-ceramide monoclonal antibodies, that have therapeutic use preferably in humanized form to treat or prevent these diseases.
L'invention concerne l'administration d'anticorps anticéramides pour traiter et empêcher un large éventail de pathologies provoquées par la destruction induite par le lymphocyte T cytolytique (CTL) - et par des dommages à la microvascularisation endothéliale, y compris le syndrome GI induit par un rayonnement, la réaction de greffe contre l'hôte, les maladies inflammatoires et les maladies auto-immunes. Nous avons également découverts de nouveaux anticorps monoclonaux anticéramides, qui ont une utilisation thérapeutique, de préférence dans la forme humanisée, pour traiter ou prévenir ces maladies.
Arap Wadih
Kolesnick Richard
Pasqualini Renate
Rotolo Jimmy
Marks & Clerk
Sloan-Kettering Institute For Cancer Research
LandOfFree
Methods for treating and preventing gi syndrome and graft... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating and preventing gi syndrome and graft..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating and preventing gi syndrome and graft... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1981181